Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Geron Q1 EPS $(0.03) Beats $(0.04) Estimate, Sales $39.60M Miss $48.22M Estimate

Author: Benzinga Newsdesk | May 07, 2025 06:01am
Geron (NASDAQ:GERN) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 66.67 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $39.60 million which missed the analyst consensus estimate of $48.22 million by 17.86 percent. This is a 12.93K percent increase over sales of $304.00 thousand the same period last year.

Posted In: GERN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist